Long-term safety of etanercept in psoriasis: Retrospective study focused on infections

OBJECTIVE: Retrospective study to evaluate the incidence of infectious adverse events in patients with psoriasis treated with etanercept. METHODS: Patients with psoriasis or psoriatic arthritis who were treated with etanercept (50 mg, administered weekly via subcutaneous injection) for ≥48 weeks wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Orsini, Diego, Narcisi, Alessandra, Arcese, Annalisa, Costanzo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Immuno-Mediated Diseases And Comorbities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536529/
https://www.ncbi.nlm.nih.gov/pubmed/27683141
http://dx.doi.org/10.1177/0300060515593252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536529/
https://www.ncbi.nlm.nih.gov/pubmed/27683141
http://dx.doi.org/10.1177/0300060515593252

Ejemplares similares